Deerfield Partners, L.P., 10% Owner at RIGEL PHARMACEUTICALS INC (RIGL), bought 650,000 shares at $8.00 ($5.2M) on 2011-05-26, disclosed to the SEC on 2011-06-07.
Open-market purchase of $5.2M RIGL by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 46,524 | $372K | 7.2% |
| 2 | $8.00 | 72,800 | $582K | 11.2% |
| 3 | $8.00 | 229,252 | $1.8M | 35.3% |
| 4 | $8.00 | 301,424 | $2.4M | 46.4% |
| Total | $8.00 avg | 650,000 | $5.2M | 100% |
| Filing → |
| ATRS | SELL | 2015-06-23 | $1.2M | — | Filing → |
| ASPX | BUY | 2015-01-28 | $84.8M | — | Filing → |
| MDCO | SELL | 2011-04-01 | $4.6M | — | Filing → |